|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Foundation Medicine, Inc. (FMI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,281,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$137 - $137 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cox Troy |
Chief Executive Officer |
• • – |
2018-07-02 |
4 |
S |
$136.66 |
$191,597 |
D/D |
(1,402) |
242,068 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$397,544 |
D/D |
(2,909) |
67,179 |
|
- |
|
| Doherty Michael J |
Head of Product Development |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$365,566 |
D/D |
(2,675) |
81,287 |
|
- |
|
| Fiedler Konstantin |
Chief Operating Officer |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$135,840 |
D/D |
(994) |
26,835 |
|
- |
|
| Ryan Jason |
Chief Financial Officer |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$465,054 |
D/D |
(3,403) |
49,170 |
|
- |
|
| Pellini Michael J |
Director |
– • – |
2018-06-15 |
4 |
AS |
$105.45 |
$369,075 |
D/D |
(3,500) |
103,711 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-05-21 |
4 |
AS |
$85.00 |
$133,450 |
D/D |
(1,570) |
70,088 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-05-21 |
4 |
OE |
$29.94 |
$47,006 |
D/D |
1,570 |
71,658 |
|
- |
|
| Cox Troy |
Chief Executive Officer |
• • – |
2018-05-16 |
4 |
AS |
$77.10 |
$166,305 |
D/D |
(2,157) |
243,470 |
|
- |
|
| Pellini Michael J |
Director |
– • – |
2018-05-15 |
4 |
AS |
$76.05 |
$266,175 |
D/D |
(3,500) |
107,211 |
|
- |
|
| Cox Troy |
Chief Executive Officer |
• • – |
2018-05-07 |
4 |
S |
$70.01 |
$494,481 |
D/D |
(7,063) |
245,627 |
|
- |
|
| Ryan Jason |
Chief Financial Officer |
• – – |
2018-04-16 |
4 |
AS |
$74.30 |
$256,261 |
D/D |
(3,449) |
52,573 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-04-16 |
4 |
AS |
$74.02 |
$243,008 |
D/D |
(3,283) |
70,088 |
|
- |
|
| Pellini Michael J |
Director |
– • – |
2018-04-16 |
4 |
AS |
$74.65 |
$261,275 |
D/D |
(3,500) |
110,711 |
|
- |
|
| Pellini Michael J |
Director |
– • – |
2018-04-03 |
4 |
AS |
$70.28 |
$959,955 |
D/D |
(13,659) |
114,211 |
|
- |
|
| Ryan Jason |
Chief Financial Officer |
• – – |
2018-04-03 |
4 |
S |
$72.40 |
$72 |
D/D |
(1) |
56,022 |
|
- |
|
| Doherty Michael J |
Head of Product Development |
• – – |
2018-04-03 |
4 |
S |
$72.40 |
$145 |
D/D |
(2) |
83,962 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-04-02 |
4 |
S |
$74.86 |
$215,871 |
D/D |
(2,883) |
73,371 |
|
- |
|
| Nallicheri Melanie |
Chief Business Officer |
• – – |
2018-04-02 |
4 |
S |
$74.88 |
$93,825 |
D/D |
(1,253) |
68,019 |
|
- |
|
| Doherty Michael J |
Head of Product Development |
• – – |
2018-04-02 |
4 |
S |
$74.87 |
$613,185 |
D/D |
(8,190) |
83,964 |
|
- |
|
| Ryan Jason |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
AS |
$74.87 |
$467,959 |
D/D |
(6,139) |
56,023 |
|
- |
|
| Fiedler Konstantin |
Chief Operating Officer |
• – – |
2018-04-02 |
4 |
S |
$74.88 |
$26,807 |
D/D |
(358) |
27,829 |
|
- |
|
| Hesslein Robert W. |
SVP and General Counsel |
• – – |
2018-04-02 |
4 |
S |
$74.88 |
$118,685 |
D/D |
(1,585) |
107,723 |
|
- |
|
| Hesslein Robert W. |
SVP and General Counsel |
• – – |
2018-04-02 |
4 |
OE |
$7.12 |
$16,689 |
D/D |
2,344 |
109,308 |
|
- |
|
| Miller Vincent A. |
Chief Medical Officer |
• – – |
2018-04-01 |
4 |
A |
$78.75 |
$1,018,395 |
D/D |
12,932 |
76,254 |
|
- |
|
409 Records found
|
|
Page 2 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
